论文部分内容阅读
目的:探究雷贝拉唑在消化性溃疡上的临床治疗效果。方法:择取2015年6月到2015年12月期间于笔者医院就诊的消化性溃疡病患共50例,按照不同用药方案分组:单用奥美拉唑的25例患者归入对照组,加用雷贝拉唑的25例患者归入研究组。对比两组的疗效与不良反应。结果:无论是总有效率还是不良反应率,研究组均要优于对照组,统计学有差异(P<0.05)。结论:临床针对消化性溃疡,可在奥美拉唑基础上加用雷贝拉唑,提高原有的临床疗效。
Objective: To investigate the clinical effect of rabeprazole on peptic ulcer. Methods: A total of 50 patients with peptic ulcer were selected in our hospital from June 2015 to December 2015. The patients were divided into groups according to different dosage regimens: 25 patients with omeprazole alone were included in the control group, plus Twenty-five patients with rabeprazole were included in the study group. The efficacy and adverse reactions of the two groups were compared. Results: Both the total effective rate and the adverse reaction rate were better in the study group than in the control group, with statistical differences (P <0.05). Conclusions: For clinical peptic ulcer, rabeprazole can be added on the basis of omeprazole to improve the original clinical curative effect.